Clinical Trial Update: Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial update evaluating the safety and effectiveness of Cardiac Resynchronization Therapy with Defibrillation (CRT-D) for h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• Cardiac Resynchronization Therapy with Defibrillation (CRT-D) (Cardiac resynchronization therapy with defibrillator)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Heart Failure, Congestive, Ventricular Fibrillation | Phase 2, Phase 3 | Status: COMPLETED